TP53 and melanoma: In the present study, we customized inactivation of S100b expression in two murine melanoma cell lines by using a CRISPR/dCas9 system that allowed for restoring intercellular levels of WT-p53 that might otherwise be bound to the S100b protein, thereby salvaging p53-mediated cell death and apoptosis.